[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Generic_Tina Tina Banerjee Tina Banerjee posts on X about ipo, $302440ks, samsung, bla the most. They currently have XX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1511682976639119365/interactions)  - X Week XXX -XX% - X Month XXXXX +274% - X Months XXXXX +281% - X Year XXXXX +441% ### Mentions: X [#](/creator/twitter::1511682976639119365/posts_active)  ### Followers: XX [#](/creator/twitter::1511682976639119365/followers)  - X Week XX +2.20% - X Month XX +2.20% - X Months XX +12% ### CreatorRank: undefined [#](/creator/twitter::1511682976639119365/influencer_rank)  ### Social Influence [#](/creator/twitter::1511682976639119365/influence) --- **Social category influence** [finance](/list/finance) [countries](/list/countries) [technology brands](/list/technology-brands) [travel destinations](/list/travel-destinations) [stocks](/list/stocks) **Social topic influence** [ipo](/topic/ipo), [$302440ks](/topic/$302440ks), [samsung](/topic/samsung), [bla](/topic/bla), [$6417t](/topic/$6417t), [$4568t](/topic/$4568t), [$8750t](/topic/$8750t), [china](/topic/china), [robot](/topic/robot), [shanghai](/topic/shanghai) ### Top Social Posts [#](/creator/twitter::1511682976639119365/posts) --- Top posts by engagements in the last XX hours "Eisai's Dayvigo approved in China. Daiichi Sankyo withdrew BLA in US. Samsung Bio secures CMO contracts. SK Bioscience expands vaccine manufacturing facility. CSPC is in outlicensing talks"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1928973619079819639) 2025-06-01 00:35:24 UTC XX followers, XX engagements "Shanghai MicroPort MedBot expects 7080% revenue growth in 1H25 with net loss narrowing to RMB 125M. Toumai Laparoscopic Surgical Robot is driving growth with new orders and overseas installations"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1947817789307142425) 2025-07-23 00:35:24 UTC XX followers, XX engagements "Celltrion's 1Q25 results show a sequential decrease in revenue and operating profit but a sequential improvement in gross profit margin. The company reaffirmed its 2025 revenue guidance of KRW5T"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1947174365701046723) 2025-07-21 05:58:40 UTC XX followers, XX engagements "Astellas sees XX% growth in Q1FY26 sales of Izervay in the U.S. In FY25 revenue from strategic brands improved XXX% YoY. Izervay Q1FY26 revenue enhances conviction on strategic brands"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1944918652643631437) 2025-07-15 00:35:16 UTC XX followers, XX engagements "Nanjing Leads Biolabs launches HK$1.1B IPO to fund its ongoing and planned clinical development and regulatory affairs of pipeline assets. The company has fetched cornerstone investment of HK$ 542M"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1946005806606139795) 2025-07-18 00:35:13 UTC XX followers, XX engagements "3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707 resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707 and strong financial performance are expected ahead"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1939845218901402107) 2025-07-01 00:35:15 UTC XX followers, XXX engagements "Hisamitsu's Q1FY26 revenue was down X% YoY due to subdued performance in Salonpas OTC products. However FY26 guidance was reiterated as Salonpas decline is seen as temporary"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1944556271887388725) 2025-07-14 00:35:17 UTC XX followers, XX engagements "Jiangsu Hengrui launches HK IPO. Wuxi Biologics to sell Germany plant. Chugai got Japan approval for gene therapy. Mayne Pharma was hit as FDA letter was made public"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1923900195932340272) 2025-05-18 00:35:25 UTC XX followers, XXX engagements "Sino Biopharmaceutical is acquiring China-based clinical-stage biopharma company LaNova Medicines for $500M enhancing its oncology capabilities and global reputation in the pharmaceutical industry"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1945643429184377311) 2025-07-17 00:35:16 UTC XX followers, XX engagements "SK Bioscience initiates global Phase X trial of PCV21 vaccine. IDT Biologika shows revenue growth in 1Q25 on track to meet 2025 guidance. 1Q25 base business revenue increased XX% YoY"  [@Generic_Tina](/creator/x/Generic_Tina) on [X](/post/tweet/1937308506954301942) 2025-06-24 00:35:16 UTC XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Generic_Tina Tina Banerjee
Tina Banerjee posts on X about ipo, $302440ks, samsung, bla the most. They currently have XX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Month XXXXX +274%
- X Months XXXXX +281%
- X Year XXXXX +441%
Mentions: X #
Followers: XX #
- X Week XX +2.20%
- X Month XX +2.20%
- X Months XX +12%
CreatorRank: undefined #
Social Influence #
Social category influence finance countries technology brands travel destinations stocks
Social topic influence ipo, $302440ks, samsung, bla, $6417t, $4568t, $8750t, china, robot, shanghai
Top Social Posts #
Top posts by engagements in the last XX hours
"Eisai's Dayvigo approved in China. Daiichi Sankyo withdrew BLA in US. Samsung Bio secures CMO contracts. SK Bioscience expands vaccine manufacturing facility. CSPC is in outlicensing talks"
@Generic_Tina on X 2025-06-01 00:35:24 UTC XX followers, XX engagements
"Shanghai MicroPort MedBot expects 7080% revenue growth in 1H25 with net loss narrowing to RMB 125M. Toumai Laparoscopic Surgical Robot is driving growth with new orders and overseas installations" @Generic_Tina on X 2025-07-23 00:35:24 UTC XX followers, XX engagements
"Celltrion's 1Q25 results show a sequential decrease in revenue and operating profit but a sequential improvement in gross profit margin. The company reaffirmed its 2025 revenue guidance of KRW5T" @Generic_Tina on X 2025-07-21 05:58:40 UTC XX followers, XX engagements
"Astellas sees XX% growth in Q1FY26 sales of Izervay in the U.S. In FY25 revenue from strategic brands improved XXX% YoY. Izervay Q1FY26 revenue enhances conviction on strategic brands" @Generic_Tina on X 2025-07-15 00:35:16 UTC XX followers, XX engagements
"Nanjing Leads Biolabs launches HK$1.1B IPO to fund its ongoing and planned clinical development and regulatory affairs of pipeline assets. The company has fetched cornerstone investment of HK$ 542M" @Generic_Tina on X 2025-07-18 00:35:13 UTC XX followers, XX engagements
"3SBio signed $6B outlicensing deal with Pfizer for SSGJ-707 resulting in spectacular rally in 3SBio shares. Global trial initiation of SSGJ-707 and strong financial performance are expected ahead" @Generic_Tina on X 2025-07-01 00:35:15 UTC XX followers, XXX engagements
"Hisamitsu's Q1FY26 revenue was down X% YoY due to subdued performance in Salonpas OTC products. However FY26 guidance was reiterated as Salonpas decline is seen as temporary" @Generic_Tina on X 2025-07-14 00:35:17 UTC XX followers, XX engagements
"Jiangsu Hengrui launches HK IPO. Wuxi Biologics to sell Germany plant. Chugai got Japan approval for gene therapy. Mayne Pharma was hit as FDA letter was made public" @Generic_Tina on X 2025-05-18 00:35:25 UTC XX followers, XXX engagements
"Sino Biopharmaceutical is acquiring China-based clinical-stage biopharma company LaNova Medicines for $500M enhancing its oncology capabilities and global reputation in the pharmaceutical industry" @Generic_Tina on X 2025-07-17 00:35:16 UTC XX followers, XX engagements
"SK Bioscience initiates global Phase X trial of PCV21 vaccine. IDT Biologika shows revenue growth in 1Q25 on track to meet 2025 guidance. 1Q25 base business revenue increased XX% YoY" @Generic_Tina on X 2025-06-24 00:35:16 UTC XX followers, XX engagements